All deals
You are viewing a shared deal. With a free account you access the full showcase and talk directly with whoever manages the deal.
DataBiome AI Diagnostics
Capital Raising Live

DataBiome AI Diagnostics

CHF 590K
Raising target
Switzerland
Switzerland
Startup
CHF 590KRaising target
Pre-seedRound stage
AnyMinimum ticket
LiveStatus

Who they are & what they do

SectorHealthcare
Industries
BiotechnologyHealth Care TechnologyPrecision MedicineDiagnostics
Company overview

DataBiome AI Diagnostics is pioneering a paradigm shift in personalized medicine by transforming complex human gut microbiome data into actionable, strain-level diagnostic insights. Operating at the intersection of biotechnology and artificial intelligence, the company bridges the missing data layer for nutritionists, clinicians, and pharmaceutical developers through a scalable B2B2C SaaS platform combined with proprietary machine learning foundation models. By converting raw sequencing data into dynamic web dashboards and clinical recommendations, DataBiome unlocks high-value predictive biomarkers for longevity, chronic gastrointestinal conditions, and oncology therapy responses.

The company leverages a highly defensible dual-engine business model that couples predictable, compounding recurring revenue from diagnostics and practitioner subscriptions with high-margin pharmaceutical data licensing and co-developed biomarker intellectual property. Backed by robust scientific validation, strategic lab partnerships across Europe, and non-dilutive institutional grants, DataBiome is uniquely positioned to capture massive tailwinds in the exploding longevity and precision medicine markets, scaling its infrastructure from Switzerland into broader European and global territories.

Key clients & traction

Labor Team WZHAW research partnershipB2B2C medical clinics
Company type Startup
Country Switzerland

Website: Confidential

Why look at this deal

Highlights

  1. 01Strain-level resolution advantage
  2. 02Proprietary AI foundation models
  3. 03High software gross margins
  4. 04Compounding data network effects

Deal snapshot

Raising targetCHF 590K
Round stagePre-seed
InstrumentEquity
Minimum ticketAny
Pre-money valuation Confidential
Equity offeringConfidential
Gross margin60%
PatentsPatent filed
Use of proceeds (3–4 items with %)Operational costs for 5 FTEs over 18 months & fixed costs / burn (approx. 50% / 900k total pool context including matching grants) WebApp development, frontend/backend, AI architecture & certifications (approx. 25% / 500k context) In-kind matching contribution for further non-dilutive Swiss/EU grants (approx. 15%) Intellectual Property & patent filings (approx. 10% / 100k context)

Locked fields are disclosed after expressing interest.

Data room

Public files are open to everyone. The rest unlock once you qualify.

For companies and advisors

Have a deal to bring to market?

Publish your deal on UCapital Dealflow and reach qualified buyers and investors. Data room, NDA and lead management included.

Disclaimer

UCapital Asset Management LLP is authorised and regulated by the Financial Conduct Authority (FCA) in the United Kingdom and by CONSOB in Italy, and operates in the United States through FINRA-licensed US partners and affiliates.

This platform serves informational and technological purposes only: it executes no market transactions, does not constitute a solicitation to invest and provides no financial advice of any kind. The platform lets users manage a deal through the technological tools made available to them, such as the CRM for lead tracking and analytics. No capital raising and no sale is executed on or through the platform: each individual deal is executed offline by the designated regulated entities, in accordance with the regulations in force in each country, their compliance frameworks and under their full responsibility.

The content is intended exclusively for eligible counterparties, professional investors and professional clients as defined by applicable regulations, and does not constitute a public offer. The information is not directed at persons in jurisdictions where its distribution or use would be contrary to local laws or regulations.

The data shown on these pages is public data or data collected and processed by UCapital. For user-created deals, the data is entered by the users themselves, who take full responsibility for what is published: the publication of a deal on the platform does not constitute a recommendation, endorsement or verification by UCapital.

The data shown may not always be real-time and may differ from what is verified in due diligence when contacting the regulated entities responsible for managing the deal. Any prices, valuations and projections are purely indicative.

Every investment carries risks, including the total loss of the capital invested. Past performance is not indicative of future results. Before any decision, investors must carry out their own assessments and consult the regulated entities managing the deal and, where appropriate, their own legal, tax and financial advisers.